Brief: Aileron Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Highlights

Rein Therapeutics

24/03/2021 20:45

March 24 (Reuters) - Aileron Therapeutics Inc  ALRN.O :
    * AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
    * Q4 LOSS PER SHARE $0.12
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.12 -- REFINITIV IBES
DATA
    * AILERON THERAPEUTICS - CASH, EQUIVALENTS & INVESTMENTS AS
OF DEC
31, 2020 WERE $13.8 MILLION VERSUS $18.3 MILLION AS OF DEC 31,
2019
    * AILERON THERAPEUTICS - EXPECTS EXISTING CASH, EQUIVALENTS
AND
INVESTMENTS WILL FUND OPERATIONS INTO SECOND HALF OF 2023

Source text for Eikon:  ID:nGNX334j7Y 
Further company coverage:  ALRN.O 

 ((Reuters.Briefs@thomsonreuters.com;))